Strength
250 mg/1
Manufacturer
AvPAKNDC
50268026815
Classification
Generic
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DOCUSATE SODIUMApproval Type
OTC MONOGRAPH DRUG
FDA Application
M007On Market Since
5/17/2017
Price Statistics
The NADAC for DOCUSATE SODIUM 250 MG SOFTGEL has been published 179 times since Jan 25, 2023, and over the history we have for it it has risen 12.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0541 per EA |
|---|---|
| All-time high | $0.0541 (Jun 24, 2026) |
| All-time low | $0.0365 (Jul 17, 2024) |
| 52-week high | $0.0541 |
| 52-week low | $0.0493 |
| Median price | $0.0493 |
| Average price | $0.0481 |
| Largest weekly change | +29.0% (Aug 21, 2024) |
| Weeks tracked | 179 |
| Tracking since | Jan 25, 2023 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DOCUSATE SODIUM 250 MG SOFTGEL?
The current National Average Drug Acquisition Cost (NADAC) for DOCUSATE SODIUM 250 MG SOFTGEL, manufactured by AvPAK, is $0.0541 per EA (NDC 50268026815), effective Jun 24, 2026.
How has the price of DOCUSATE SODIUM 250 MG SOFTGEL changed over time?
Over the history we have for it, the NADAC for DOCUSATE SODIUM 250 MG SOFTGEL has risen 12.7%. It has been tracked across 179 weekly CMS publications since Jan 25, 2023.
What are the highest and lowest recorded NADAC prices for DOCUSATE SODIUM 250 MG SOFTGEL?
Since Jan 25, 2023, the NADAC for DOCUSATE SODIUM 250 MG SOFTGEL has ranged from a low of $0.0365 (Jul 17, 2024) to a high of $0.0541 (Jun 24, 2026), with a median of $0.0493 per EA.
Are there cheaper alternatives to DOCUSATE SODIUM 250 MG SOFTGEL?
2 NADAC-published products share the same active ingredient, strength, and dosage form as DOCUSATE SODIUM 250 MG SOFTGEL, but none are currently priced below it.
Who manufactures DOCUSATE SODIUM 250 MG SOFTGEL?
DOCUSATE SODIUM 250 MG SOFTGEL (NDC 50268026815) is labeled by AvPAK, and CMS classifies it as a generic product.
Related Drugs
Same classification